TNFα depleting therapy improves fertility and animal welfare in TNFα-driven transgenic models of polyarthritis when administered in their routine breeding.

about

TNFα depleting therapy improves fertility and animal welfare in TNFα-driven transgenic models of polyarthritis when administered in their routine breeding.

Item

http://www.wikidata.org/entity/Q50233826

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

TNFα depleting therapy improve ...... red in their routine breeding.

@en

TNFα depleting therapy improve ...... red in their routine breeding.

@nl

type

Item

label

TNFα depleting therapy improve ...... red in their routine breeding.

@en

TNFα depleting therapy improve ...... red in their routine breeding.

@nl

prefLabel

TNFα depleting therapy improve ...... red in their routine breeding.

@en

TNFα depleting therapy improve ...... red in their routine breeding.

@nl

P1476

TNFα depleting therapy improve ...... red in their routine breeding.

@en

P2093

Amy J Naylor

http://www.w3.org/2001/XMLSchema#string

Atif N Saghir

http://www.w3.org/2001/XMLSchema#string

Guillaume Desanti

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

Animal models of anorexia and cachexia.

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody.

Humane endpoints for laboratory animals used in regulatory testing.

Anti-inflammatory effects of opioids.

P304

59-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0023677217707985

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rowan Hardy

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28480797

http://www.w3.org/2001/XMLSchema#string

P932

5802519

http://www.w3.org/2001/XMLSchema#string